ARDELYX, INC. Retained Earnings
ARDELYX, INC. (ARDX) had Retained Earnings of -$1.00 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$1.00B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$984.54M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$946.94M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$946.53M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$1.00B 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$984.54M 10-Q · filed 2026-04-30 |
| 2025-12-31 | -$946.94M 10-Q · filed 2026-08-06 |
| 2025-09-30 | -$946.53M 10-Q · filed 2025-10-30 |
| 2025-06-30 | -$945.56M 10-Q · filed 2025-08-04 |
| 2025-03-31 | -$926.48M 10-Q · filed 2025-05-01 |
| 2024-12-31 | -$885.34M 10-K · filed 2026-02-19 |
| 2024-09-30 | -$889.99M 10-Q · filed 2024-10-31 |
| 2024-06-30 | -$889.18M 10-Q · filed 2024-08-01 |
| 2024-03-31 | -$872.72M 10-Q · filed 2024-05-02 |
| 2023-12-31 | -$846.20M 10-K · filed 2025-02-20 |
| 2023-09-30 | -$817.40M 10-Q · filed 2023-10-31 |
| 2023-06-30 | -$824.03M 10-Q · filed 2023-08-02 |
| 2023-03-31 | -$806.91M 10-Q · filed 2023-05-03 |
| 2022-12-31 | -$780.14M 10-K · filed 2024-02-22 |
| 2022-09-30 | -$790.83M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$767.94M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$741.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$712.93M 10-K · filed 2023-03-02 |
| 2021-09-30 | -$676.70M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$633.11M 10-Q · filed 2021-08-13 |
| 2021-03-31 | -$587.92M 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$554.76M 10-K · filed 2022-02-28 |
| 2020-09-30 | -$525.89M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$507.78M 10-Q · filed 2020-08-06 |
| 2020-03-31 | -$482.82M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$460.45M 10-K · filed 2021-03-08 |
| 2019-09-30 | -$440.66M 10-Q · filed 2019-11-06 |
| 2019-06-30 | -$417.12M 10-Q · filed 2019-08-09 |
| 2019-03-31 | -$391.66M 10-Q · filed 2019-05-07 |
| 2018-12-31 | -$365.51M 10-K · filed 2020-03-06 |
| 2018-09-30 | -$337.65M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$313.52M 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$291.23M 10-Q · filed 2018-05-08 |
| 2018-01-02 | $4.00M 10-Q · filed 2018-11-07 |
| 2018-01-01 | $4.00M 10-K · filed 2019-03-06 |
| 2017-12-31 | -$278.21M 10-K · filed 2019-03-06 |
| 2017-09-30 | -$288.33M 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$267.60M 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$241.88M 10-Q · filed 2017-05-05 |
| 2016-12-31 | -$213.88M 10-K · filed 2018-03-14 |
| 2016-09-30 | -$182.60M 10-Q · filed 2016-11-07 |
| 2016-06-30 | -$153.57M 10-Q · filed 2016-08-08 |
| 2016-03-31 | -$124.95M 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$101.49M 10-K · filed 2017-02-17 |
| 2015-09-30 | -$84.49M 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$66.36M 10-Q · filed 2015-08-12 |
| 2015-03-31 | -$75.37M 10-Q · filed 2015-05-12 |
| 2014-12-31 | -$71.87M 10-K · filed 2016-03-04 |
| 2014-09-30 | -$67.90M 10-Q · filed 2014-11-07 |
| 2014-06-30 | -$67.97M 10-Q · filed 2014-08-08 |
| 2013-12-31 | -$68.65M 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |